Skip to menu Skip to content Skip to footer

2008

Journal Article

Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy

Degenhardt, Louisa, Gibson, Amy, Mattick, Richard P. and Hall, Wayne (2008). Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy. Drug and Alcohol Review, 27 (1), 1-3. doi: 10.1080/09595230701711157

Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy

2008

Conference Publication

Can addicts consent to research that administers their drug of addiction?

Carter, A. N., Collin, S. P. and Hall, W. D. (2008). Can addicts consent to research that administers their drug of addiction?. Neuroscience 2008, Washington, DC, U. S. A., 15-19 November 2008. Washington, DC, U. S. A.: Society for Neuroscience.

Can addicts consent to research that administers their drug of addiction?

2008

Book Chapter

Assessing the population health impact of cannabis use

Hall, Wayne (2008). Assessing the population health impact of cannabis use. A cannabis reader : Global issues and local experiences : Perspectives on cannabis controversies, treatment and regulation in Europe. (pp. 157-171) edited by Sharon Rodner Sznitman, Borje Olsson and Robin Room. Luxembourg: Office for Official Publications of the European Communities.

Assessing the population health impact of cannabis use

2008

Book Chapter

Drug use and drug dependence

Hall, Wayne D. and Farrell, M. (2008). Drug use and drug dependence. Essential Psychiatry. (pp. 230-249) edited by Robin Murray, Kenneth S. Kendler, Peter McGuffin, Simon Wessely and David J. Castle. Cambridge, UK ; New York: Cambridge University Press. doi: 10.1017/CBO9780511544125.012

Drug use and drug dependence

2008

Other Outputs

Identifying cost-effective interventions to reduce the burden of harm associated with alcohol misuse in Australia

Doran, C., Vos, T., Cobiac, L., Hall, W., Asamoah, I., Wallace, A., Naidoo, S., Byrnes, J., Fowler, G. and Arnett, K. (2008). Identifying cost-effective interventions to reduce the burden of harm associated with alcohol misuse in Australia. Brisbane, Qld, Australia: The University of Queensland.

Identifying cost-effective interventions to reduce the burden of harm associated with alcohol misuse in Australia

2008

Book Chapter

Cannabis abuse and dependence

Hall, Wayne D., Degenhardt, L. and Patton, G. (2008). Cannabis abuse and dependence. Adolescent addiction: Epidemiology, assessment and treatment. (pp. 117-148) edited by Cecilia A. Essau. Amsterdam: Academic Press. doi: 10.1016/B978-012373625-3.50006-1

Cannabis abuse and dependence

2008

Book Chapter

Illicit drug use and the burden of disease

Hall, Wayne D., Degenhardt, L. and Sindicich, N. (2008). Illicit drug use and the burden of disease. International Encyclopedia of Public Health. (pp. 523-530) edited by Kristian Heggenhougen and Stella Quah. San Diego, CA, USA: Academic Press. doi: 10.1016/B978-012373960-5.00355-5

Illicit drug use and the burden of disease

2007

Journal Article

Learning from episodes of degradation and recovery in variable Australian rangelands

Smith, D. Mark Stafford, McKeon, Greg M., Watson, Ian W., Henry, Beverley K., Stone, Grant S., Hall, Wayne B. and Howden, S. Mark (2007). Learning from episodes of degradation and recovery in variable Australian rangelands. Proceedings of the National Academy of Sciences of the United States of America, 104 (52), 20690-20695. doi: 10.1073/pnas.0704837104

Learning from episodes of degradation and recovery in variable Australian rangelands

2007

Journal Article

UK classification of cannabis: is a change needed and why?

Degenhardt, Louisa, Hall, Wayne D., Roxburgh, Amanda and Mattick, Richard P. (2007). UK classification of cannabis: is a change needed and why?. Lancet, 370 (9598), 1541-1541. doi: 10.1016/S0140-6736(07)61655-9

UK classification of cannabis: is a change needed and why?

2007

Journal Article

Swedish snus for tobacco harm reduction – Authors' reply

Gartner, Coral E., Hall, Wayne D., Vos, Theo, Bertram, Melanie Y. and Wallace, Angela L. (2007). Swedish snus for tobacco harm reduction – Authors' reply. The Lancet, 370 (9594), 1206-1207. doi: 10.1016/S0140-6736(07)61532-3

Swedish snus for tobacco harm reduction – Authors' reply

2007

Other Outputs

The Ethical Use of Psychosocially Assisted Pharmacological Treatments for Opioid Dependence

Carter, A. and Hall, W. (2007). The Ethical Use of Psychosocially Assisted Pharmacological Treatments for Opioid Dependence. Geneva: World Health Organisation.

The Ethical Use of Psychosocially Assisted Pharmacological Treatments for Opioid Dependence

2007

Journal Article

Should the health community promote smokeless tobacco (snus) as a harm reduction measure?

Gartner, C. E., Hall, W. D., Chapman, S. and Freeman, B. (2007). Should the health community promote smokeless tobacco (snus) as a harm reduction measure?. PLoS Medicine, 4 (7), 1138-1141. doi: 10.1371/journal.pmed.0040185

Should the health community promote smokeless tobacco (snus) as a harm reduction measure?

2007

Journal Article

Opioid overdose deaths can occur in patients with naltrexone implants - In reply

Gibson, Amy E., Degenhardt, Louisa J. and Hall, Wayne D. (2007). Opioid overdose deaths can occur in patients with naltrexone implants - In reply. Medical Journal of Australia, 187 (1), 56-57. doi: 10.5694/j.1326-5377.2007.tb01126.x

Opioid overdose deaths can occur in patients with naltrexone implants - In reply

2007

Journal Article

Reply: Cannabis-induced psychosis among aboriginal people in the Northwest Territories

Degenhardt, L. and Hall, W. D. (2007). Reply: Cannabis-induced psychosis among aboriginal people in the Northwest Territories. Canadian Journal of Psychiatry, 52 (7), 475-476. doi: 10.1177/070674370705200713

Reply: Cannabis-induced psychosis among aboriginal people in the Northwest Territories

2007

Book Chapter

Drug Addiction, Society and Ethics

Hall, Wayne and Carter, Adrian (2007). Drug Addiction, Society and Ethics. Principles of Health Care Ethics: Second Edition. (pp. 639-645) Chichester, UK: John Wiley and Sons. doi: 10.1002/9780470510544.ch87

Drug Addiction, Society and Ethics

2007

Journal Article

What's in a name?

Hall, W. D. (2007). What's in a name?. Addiction, 102 (5), 692-692. doi: 10.1111/j.1360-0443.2007.01812.x

What's in a name?

2007

Journal Article

Cost-effectiveness analysis of genetic screening for the Taq1B polymorphism in the secondary prevention of coronary heart disease

Kemp, Linda K., Doran, Christopher M., Vos, Theo and Hall, Wayne (2007). Cost-effectiveness analysis of genetic screening for the Taq1B polymorphism in the secondary prevention of coronary heart disease. Expert Review of Pharmacoeconomics and Outcomes Research, 7 (2), 119-128. doi: 10.1586/14737167.7.2.119

Cost-effectiveness analysis of genetic screening for the Taq1B polymorphism in the secondary prevention of coronary heart disease

2007

Journal Article

Psychoactive drugs of misuse: rationalising the irrational

Hall, Wayne (2007). Psychoactive drugs of misuse: rationalising the irrational. Lancet, 369 (9566), 972-972. doi: 10.1016/S0140-6736(07)60471-1

Psychoactive drugs of misuse: rationalising the irrational

2007

Journal Article

Review of "Biomedicalization of alcohol studies: Ideological shifts and institutional challenges"

Hall, Wayne (2007). Review of "Biomedicalization of alcohol studies: Ideological shifts and institutional challenges". Addiction, 102 (3), 494-495. doi: 10.1111/j.1360-0443.2007.01788.x

Review of "Biomedicalization of alcohol studies: Ideological shifts and institutional challenges"

2007

Journal Article

Assessing the impact of prescribed medicines on health outcomes

Hall, Wayne D. and Lucke, Jayne (2007). Assessing the impact of prescribed medicines on health outcomes. Australia and New Zealand Health Policy, 4 (1) 1, 1-9. doi: 10.1186/1743-8462-4-1

Assessing the impact of prescribed medicines on health outcomes